000788，董事长被批准逮捕！

Core Viewpoint - The chairman and president of Peking University Pharmaceutical, Xu Xiren, has been approved for arrest due to suspected criminal activities, impacting the company's leadership structure and raising concerns about governance [2][4]. Company Overview - Peking University Pharmaceutical, originally established in 1965 as Southwest Synthetic Pharmaceutical Factory, was listed on the Shenzhen Stock Exchange in 1997. The company specializes in drug research, production, and sales [5]. - In December of the previous year, New Advantage International acquired 100% of Southwest Synthetic Pharmaceutical Group's shares for 1 yuan, indirectly gaining control of Peking University Pharmaceutical. Xu Xiren became the actual controller of the company and was elected chairman in April of this year [5]. Leadership Changes - Following Xu Xiren's temporary inability to perform his duties due to personal reasons, the board authorized Chen Yuezhong to act as chairman and Yu Mengchuan to assume the roles of president and legal representative [4]. - The company confirmed that Xu Xiren was criminally detained on October 29 and is cooperating with investigations, leading to his arrest approval by the Chongqing Jiangbei District People's Procuratorate [4]. Financial Performance - In the third quarter, Peking University Pharmaceutical reported revenue of 1.231 billion yuan, a year-on-year decrease of 19.76%. However, the net profit attributable to shareholders increased by 4.31% to 136 million yuan [7]. - As of November 12, the company's stock price was 6.68 yuan per share, with a total market capitalization of 4 billion yuan [8]. Current Status - The company stated that there has been no change in control, the board is operating normally, and financial and operational management remains stable [5].